KR920008374B1 - 항종양 면역증강효과가 있는 단백다당체(G 009)를 생성하는 가노데르마루시덤(Ganoderma lucidum) IY 009 - Google Patents

항종양 면역증강효과가 있는 단백다당체(G 009)를 생성하는 가노데르마루시덤(Ganoderma lucidum) IY 009 Download PDF

Info

Publication number
KR920008374B1
KR920008374B1 KR1019900019877A KR900019877A KR920008374B1 KR 920008374 B1 KR920008374 B1 KR 920008374B1 KR 1019900019877 A KR1019900019877 A KR 1019900019877A KR 900019877 A KR900019877 A KR 900019877A KR 920008374 B1 KR920008374 B1 KR 920008374B1
Authority
KR
South Korea
Prior art keywords
cells
mice
days
minutes
strains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019900019877A
Other languages
English (en)
Korean (ko)
Other versions
KR920012420A (ko
Inventor
이권행
정훈
이준우
정천희
Original Assignee
일양약품 주식회사
정형식
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to KR1019900019877A priority Critical patent/KR920008374B1/ko
Application filed by 일양약품 주식회사, 정형식 filed Critical 일양약품 주식회사
Priority to RU93043871/13A priority patent/RU2082755C1/ru
Priority to CA002097821A priority patent/CA2097821C/en
Priority to JP4-500088A priority patent/JPH084494B2/ja
Priority to PCT/KR1991/000032 priority patent/WO1992010562A1/ja
Priority to EP19910920729 priority patent/EP0563383A4/en
Priority to AU89515/91A priority patent/AU8951591A/en
Publication of KR920012420A publication Critical patent/KR920012420A/ko
Application granted granted Critical
Publication of KR920008374B1 publication Critical patent/KR920008374B1/ko
Priority to US08/539,260 priority patent/US5721134A/en
Priority to AU12238/97A priority patent/AU1223897A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/375—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from Basidiomycetes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Botany (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019900019877A 1990-12-04 1990-12-04 항종양 면역증강효과가 있는 단백다당체(G 009)를 생성하는 가노데르마루시덤(Ganoderma lucidum) IY 009 Expired KR920008374B1 (ko)

Priority Applications (9)

Application Number Priority Date Filing Date Title
KR1019900019877A KR920008374B1 (ko) 1990-12-04 1990-12-04 항종양 면역증강효과가 있는 단백다당체(G 009)를 생성하는 가노데르마루시덤(Ganoderma lucidum) IY 009
CA002097821A CA2097821C (en) 1990-12-04 1991-12-04 Ganoderma lucidum iy009 which produces proteoglycan(g009) having effect of enhancing antitumor immunity
JP4-500088A JPH084494B2 (ja) 1990-12-04 1991-12-04 抗腫瘍免疫増強効果のある蛋白多糖体（Ｇ００９）を生成するガノデルマルシダム（Ｇａｎｏｄｅｒｍａｌｕｃｉｄｕｍ）ＩＹ００９
PCT/KR1991/000032 WO1992010562A1 (en) 1990-12-04 1991-12-04 Ganoderma lucidium iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity
RU93043871/13A RU2082755C1 (ru) 1990-12-04 1991-12-04 Штамм ganoderma lucidum - продуцент протеогликана gоо9, обладающий противоопухолевой и иммуностимулирующей активностью
EP19910920729 EP0563383A4 (en) 1990-12-04 1991-12-04 (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity
AU89515/91A AU8951591A (en) 1990-12-04 1991-12-04 (ganoderma lucidium) iy009 which produces proteoglycan (g009) having effect of enhancing antitumor immunity
US08/539,260 US5721134A (en) 1990-12-04 1995-10-04 Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) having effect of antitumor immunity
AU12238/97A AU1223897A (en) 1990-12-04 1997-01-20 Ganoderma lucidum IY009 which produces proteoglycan G009 effective in enhancing antitumor immunity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019900019877A KR920008374B1 (ko) 1990-12-04 1990-12-04 항종양 면역증강효과가 있는 단백다당체(G 009)를 생성하는 가노데르마루시덤(Ganoderma lucidum) IY 009

Publications (2)

Publication Number Publication Date
KR920012420A KR920012420A (ko) 1992-07-27
KR920008374B1 true KR920008374B1 (ko) 1992-09-26

Family

ID=19307028

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900019877A Expired KR920008374B1 (ko) 1990-12-04 1990-12-04 항종양 면역증강효과가 있는 단백다당체(G 009)를 생성하는 가노데르마루시덤(Ganoderma lucidum) IY 009

Country Status (7)

Country Link
EP (1) EP0563383A4 (cg-RX-API-DMAC7.html)
JP (1) JPH084494B2 (cg-RX-API-DMAC7.html)
KR (1) KR920008374B1 (cg-RX-API-DMAC7.html)
AU (2) AU8951591A (cg-RX-API-DMAC7.html)
CA (1) CA2097821C (cg-RX-API-DMAC7.html)
RU (1) RU2082755C1 (cg-RX-API-DMAC7.html)
WO (1) WO1992010562A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001131083A (ja) * 1999-11-01 2001-05-15 Sakamoto Bio:Kk 鹿角霊芝抽出物活性物質及びそれを含む医薬、健康食品、化粧料
RU2322491C1 (ru) * 2006-06-13 2008-04-20 Общество с ограниченной ответственностью "Сириус" Штамм lecanicillium sp. 347а - продуцент комплекса биологически активных соединений
RU2007145748A (ru) * 2007-12-11 2009-06-20 ОАО Завод экологической техники и экопитания "ДИОД" (RU) Штамм гриба hypsizygus ulmarius (bull.) redhead s-ulm1, используемый для получения средства, обладающего противоопухолевой активностью и антиоксидантным действием и способ получения средства, обладающего противоопухолевой активностью и антиоксидантным действием, на основе этого штамма
RU2373276C1 (ru) * 2008-06-25 2009-11-20 Татьяна Германовна Михеева Штамм гриба penicillium verrucosum, используемый для получения средства, обладающего иммуномодулирующими свойствами, и средство-иммуномодулятор на его основе
RU2416418C1 (ru) * 2009-12-10 2011-04-20 Открытое Акционерное Общество Завод Экологической Техники И Экопитания "Диод" Способ получения средства, обладающего противоопухолевой активностью, и средство, полученное этим способом (варианты)
RU2418062C1 (ru) * 2009-12-25 2011-05-10 Лариса Михайловна Краснопольская Способ получения средства, обладающего противоопухолевой активностью, и средство, обладающее противоопухолевой активностью
RU2499040C2 (ru) * 2011-07-15 2013-11-20 Федеральное государственное образовательное бюджетное учреждение высшего профессионального образования "Российский государственный университет нефти и газа имени И.М. Губкина" Способ получения средства, обладающего противоопухолевой активностью
SG11201606169PA (en) 2014-01-27 2016-08-30 Rennovia Inc Conversion of fructose-containing feedstocks to hmf-containing product
CN108779088B (zh) 2016-01-13 2021-10-08 斯道拉恩索公司 2,5-呋喃二甲酸及其中间体和衍生物的制备方法
EP3652161A1 (en) 2017-07-12 2020-05-20 Stora Enso Oyj Purified 2,5-furandicarboxylic acid pathway products
CN117683645B (zh) * 2024-02-04 2024-05-24 云南省农业科学院生物技术与种质资源研究所 一种亮盖灵芝菌株l4914及其栽培方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5452796A (en) * 1977-09-30 1979-04-25 Sato Akihiko Production of krebshemmende substance
JPS5775926A (en) * 1980-10-29 1982-05-12 Teikoku Chem Ind Corp Ltd Production of antitumor substance

Also Published As

Publication number Publication date
JPH084494B1 (cg-RX-API-DMAC7.html) 1996-01-24
CA2097821C (en) 1997-01-21
CA2097821A1 (en) 1992-06-05
KR920012420A (ko) 1992-07-27
AU8951591A (en) 1992-07-08
EP0563383A4 (en) 1994-07-13
AU1223897A (en) 1997-05-15
WO1992010562A1 (en) 1992-06-25
RU2082755C1 (ru) 1997-06-27
EP0563383A1 (en) 1993-10-06
JPH084494B2 (ja) 1996-01-24

Similar Documents

Publication Publication Date Title
Johns et al. Further fractionations of histones from calf thymus
Fujii et al. Isolation and characterization of a new antitumor polysaccharide, KS-2, extracted from culture mycelia of Lentinus edodes
Mescher et al. Protein and carbohydrate composition of the cell envelope of Halobacterium salinarium
Komatsu et al. Flammulin, a basic protein of Flammulina velutipes with antitumor activities
Bessler et al. Induction of lymphocyte proliferation and membrane changes by lipopeptide derivatives of the lipoprotein from the outer membrane of Escherichia coli
US4289688A (en) Protein-bound polysaccharides
Barak et al. Lectin of Sclerotium rolfsii: its purification and possible function in fungal‐fungal interaction
RU2082755C1 (ru) Штамм ganoderma lucidum - продуцент протеогликана gоо9, обладающий противоопухолевой и иммуностимулирующей активностью
KR920010763B1 (ko) 항종양 면역증강효과가 있는 단백다당체(g 009)
De-Angeli et al. Effect of L-asparaginase from Aspergillus terreus on ascites sarcoma in the rat
Khairallah et al. A vasopressor lipid in incubated plasma
Kieras et al. Properties of ribulose-1, 5-diphosphate carboxylase (carboxydismutase) from Chinese cabbage and photosynthetic microorganisms
JPWO1992010562A1 (ja) 抗腫瘍免疫増強効果のある蛋白多糖体（Ｇ００９）を生成するガノデルマルシダム（Ｇａｎｏｄｅｒｍａｌｕｃｉｄｕｍ）ＩＹ００９
Nisselbaum et al. Immunochemical studies of functionally similar enzymes
KR920008373B1 (ko) 항종양 면역증강효과가 있는 단백다당체(C 909)를 생성하는 코르디셉스(Crdeyceps sp.) IY 909
KR930002831B1 (ko) 항종양 면역증강효과가 있는 단백다당체(c 909)
KR920008375B1 (ko) 항종양 면역증강효과가 있는 단백다당체(S 818)를 생성하는 균주 쉬조필럼 콤뮨(Schizophyllum commune) IY 818
KR930002830B1 (ko) 항종양 면역증강효과가 있는 단백다당체(s 818)
US5721134A (en) Ganoderma lucidum KCCM 10045 which produces proteoglycan (G009) having effect of antitumor immunity
JPWO1992010202A1 (ja) 抗腫瘍免疫増強効果のある蛋白多糖體（ｇ００９）
Ishiguro et al. Hemopexin levels in mice
TANAMOTO et al. A Compound Possessing Antitumor and Interferon-Inducing Acticites Derived from the Common Antigen (OEP) of Pseudomonas aeruginosa
US4524026A (en) Novel proteinous cancer-cell proliferation inhibitory factors
KR900002671B1 (ko) 종양면역 증강효과가 있는 단백다당체(리오필란 a)
KR840000505B1 (ko) 항암성 다당류의 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 11

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 12

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 13

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 14

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 15

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 16

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 17

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 18

FPAY Annual fee payment

Payment date: 20090925

Year of fee payment: 18

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20100927

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20100927

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000

R18-X000 Changes to party contact information recorded

St.27 status event code: A-5-5-R10-R18-oth-X000